Travel and Flight Restriction
28 Dec 2021
| Total Cases | 1,266,559 |
| New Cases |
574
|
| New Cases (per 1 million citizens) | 205.98 |
| Transmission Rate | n/a |
| COVID-19 Hazard & Exposure | 2.4 |
| Socio-Economic Vulnerability | 1 |
| Health Conditions | 0.5 |
| Access to Health Care | 1.4 |
| Infrastructure | 1.4 |
| Lack of Coping Capacity (Hazard-Independent) | 2.5 |
| Lack of Coping Capacity | 1.7 |
| COVID-19 Lack of Coping Capacity | 0.9 |
| COVID-19 Risk | 2.8 |
| COVID-19 Risk Class | Low |
| Rank | 168 |
| COVID-19 Total Vaccination | 4,515,950 |
| COVID-19 Daily Vaccination | 589 |
| COVID-19 Vacc. (per 100 citizens) | 164.21 |
| COVID-19 Daily Vacc. (per 1 million citizens) | 214 |
| Date | Vaccine | Total Vaccinated |
|---|---|---|
| 14 Oct 2022 | Pfizer/BioNTech | 3,328,735 |
| 14 Oct 2022 | Moderna | 329,395 |
| 14 Oct 2022 | Johnson&Johnson | 295,813 |
| Air Transport, Passengers Carried | 1 |
| Point of Entry | 6 |
| Access to Cities | 7.1 |
| Mobile Cellular Subscriptions (per 100 people) | 1.9 |
| Internet Users | 2.6 |
| COVID-19 Vulnerability | 7.7 |
| Drinking Water | 0.4 |
| COVID-19 Hazard & Exposure | 2.4 |
| Population Living in Slums | n/a |
| Corruption Perception Index | 4 |
| Hospital Bed | 0.9 |
| Health System Capacity | 0.45 |
| Immunization Coverage | 1.63 |
| Health Capacity Specific to COVID-19 | 0.9 |
| COVID-19 Lack of Coping Capacity | 0.9 |
| Human Development Index | 0.87 |
| Incidence of Tuberculosis (per 10,000 people) | 50 |
| Malaria Incidence (per 1,000 people) | No data |
| Estimated Number of People Living With HIV (%) | 0.2 |
| Air Transport, Passengers Carried | 26,031 |
| Mobile Cellular Subscriptions (per 100 people) | 163.87 |
| Total Population | 2,759,631 |
| Land area (sq. km) | 62,674 |
| Year | Type | Total Affected | Total Deaths |
|---|---|---|---|
| 2018 | Drought / Drought | ||
| 2018 | Extreme temperature / Cold wave | 5 |